# WYOST

NDC: 61314-228
Generic name: denosumab
Labeler / Manufacturer: Sandoz Inc
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION
Routes: SUBCUTANEOUS
Marketing started: 20250602

FDA application: BLA761362

## Active ingredients

- DENOSUMAB: 120 mg/1.7mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"61314-228"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=61314-228
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=69e4890d-5dd9-42a5-aa41-ce50635eaed7